SREBP1 INDUCES RESISTANCE TO HIF-2α ANTAGONIST IN CLEAR CELL RENAL CELL CARCINOMA

被引：0
|
作者：
Son, Da Hyeon
Lee, Young Ju
Kim, Hyo Eun
Kim, Eun Song
Park, Sung Yul
Yoon, Young Eun
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD51-08
引用
收藏
页码：E1067 / E1068
页数：2
相关论文
共 50 条
  • [31] MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
    Kinget, Lisa
    Roussel, Eduard
    Verbiest, Annelies
    Albersen, Maarten
    Rodriguez-Antona, Cristina
    Grana-Castro, Osvaldo
    Inglada-Perez, Lucia
    Zucman-Rossi, Jessica
    Couchy, Gabrielle
    Job, Sylvie
    de Reynies, Aurelien
    Laenen, Annouschka
    Baldewijns, Marcella
    Beuselinck, Benoit
    CANCERS, 2021, 13 (12)
  • [32] Investigating the association of cytoplasmic and nuclear HIF-2 expression with cancer specific survival (CSS) in clear cell renal cell carcinoma
    Kroeger, Nils
    Seligson, David B.
    Signoretti, Sabina
    Yu, Hong
    Birkhaeuser, Frederic D.
    Magyar, Clara
    Huang, Jiaoti
    Riss, Joseph
    Kabbinavar, Fairooz F.
    Belldegrun, Arie S.
    Pantuck, Allan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [33] ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma
    Yangsook Song Green
    Maria C. Ferreira dos Santos
    Daniel G. Fuja
    Ethan C. Reichert
    Alexandre R. Campos
    Sophie J. Cowman
    Karen Acuña Pilarte
    Jessica Kohan
    Sheryl R. Tripp
    Elizabeth A. Leibold
    Deepika Sirohi
    Neeraj Agarwal
    Xiaohui Liu
    Mei Yee Koh
    Oncogene, 2022, 41 : 4709 - 4723
  • [34] ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma
    Green, Yangsook Song
    dos Santos, Maria C. Ferreira
    Fuja, Daniel
    Reichert, Ethan
    Campos, Alexandre R.
    Cowman, Sophie J.
    Pilarte, Karen Acuna
    Kohan, Jessica
    Tripp, Sheryl R.
    Leibold, Elizabeth A.
    Sirohi, Deepika
    Agarwal, Neeraj
    Liu, Xiaohui
    Koh, Mei Yee
    ONCOGENE, 2022, 41 (42) : 4709 - 4723
  • [35] Targeting HIF2α in Clear-Cell Renal Cell Carcinoma
    Ricketts, Christopher J.
    Crooks, Daniel R.
    Linehan, W. Marston
    CANCER CELL, 2016, 30 (04) : 515 - 517
  • [36] SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth
    Wang, Tong-bing
    Geng, Mei
    Jin, Hua
    Tang, Ai-guo
    Sun, Hao
    Zhou, Liu-zheng
    Chen, Bin-hai
    Shen, Gang
    Sun, Qiang
    CELL DEATH & DISEASE, 2021, 12 (08)
  • [37] POOR PROGNOSIS AND ADVANCED CLINICOPATHOLOGICAL FEATURES OF CLEAR CELL RENAL CELL CARCINOMA (CCRCC) ARE ASSOCIATED WITH CYTOPLASMIC SUBCELLULAR LOCALIZATION OF HIF-2α
    Kroeger, Nils
    Seligson, David
    Signoretti, Sabina
    Yu, Hong
    Logan, Joshua
    Birkhaeuser, Frederic
    Magyar, Clara
    Huang, Jiaoti
    Riss, Joseph
    Kabbinavar, Fairooz
    Belldegrun, Arie
    Pantuck, Allan
    JOURNAL OF UROLOGY, 2013, 189 (04): : E439 - E440
  • [38] SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth
    Tong-bing Wang
    Mei Geng
    Hua Jin
    Ai-guo Tang
    Hao Sun
    Liu-zheng Zhou
    Bin-hai Chen
    Gang Shen
    Qiang Sun
    Cell Death & Disease, 12
  • [39] PTEN suppression of YY1 induces HIF-2 activity in von hippel lindau null renal cell carcinoma
    Petrella, Brenda L.
    Brinckerhoff, Constance E.
    CANCER BIOLOGY & THERAPY, 2009, 8 (14) : 1389 - 1401
  • [40] Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma
    Nguyen, Charles B.
    Oh, Eugene
    Bahar, Piroz
    Vaishampayan, Ulka N.
    Else, Tobias
    Alva, Ajjai S.
    CANCERS, 2024, 16 (03)
12345